Standigm

Standigm is a biopharmaceutical company that uses artificial intelligence (AI) to streamline and accelerate the process of developing new medications. The company employs advanced AI platforms to identify novel drug targets, design compounds, and optimize lead molecules. Standigm’s technology covers various stages of drug discovery, from target identification to lead generation, with a focus on reducing costs and time compared to traditional methods.

Persist AI

Persist AI is a pharmaceutical technology company that combines artificial intelligence and robotics to accelerate drug formulation development. They offer a cloud lab service, allowing scientists to design experiments remotely while robots execute them.

21 Companies Harnessing Artificial Intelligence to Accelerate Drug Discovery

Discover how these 21 innovative companies are leveraging the power of Artificial Intelligence to revolutionize the drug discovery process. Explore cutting-edge AI-driven solutions that are shaping the future of pharmaceutical research and driving breakthroughs in healthcare.

XtalPi

XtalPi is a research and development company focused on integrating artificial intelligence, quantum physics, cloud computing, and robotics to accelerate drug discovery and materials science innovation. The company also develops automation systems for chemical synthesis and crystallization processes. 

Insilico Medicine

Insilico Medicine is a biotechnology company that leverages artificial intelligence to revolutionize drug discovery and development. The company focuses on using advanced machine learning techniques to accelerate the process of identifying new drug targets, designing novel molecules, and optimizing clinical trials. 

Healx

Healx is a biotechnology company focused on accelerating the discovery and development of treatments for rare diseases. The company utilizes artificial intelligence and machine learning to identify potential drug candidates and repurpose existing drugs for faster and more cost-effective solutions for patients with unmet medical needs. 

Recursion Pharmaceuticals

Recursion Pharmaceuticals is a biotechnology company that combines advanced technology with biological research to develop new medicines. They use large datasets of biological information, which they analyze using powerful computers and artificial intelligence. 

Valo Health

Valo Health is a technology company that transforms drug discovery and development using human-centric data and artificial intelligence. Valo integrates data across the entire drug development lifecycle into a unified architecture.

Insitro

Insitro is a drug discovery and development company that combines machine learning and high-throughput biology to create new medicines.The company uses artificial intelligence to analyze large-scale biological data, identify potential drug targets, and design more effective therapies.

Deep Genomics

Deep Genomics develops RNA-based therapies using artificial intelligence. Their AI platform analyzes genomic data to identify therapeutic targets and design drug candidates for genetic diseases. The company focuses on treating metabolic disorders and neurological conditions. Their proprietary technology, including the AI Workbench and BigRNA foundation model, enables efficient discovery of novel biological mechanisms and potential treatments that traditional methods might miss.